Live Cell Imaging Market To Reach $3.54 Billion By 2027. Gro...| MENAFN.COM

Friday, 09 December 2022 06:27 GMT

Live Cell Imaging Market To Reach $3.54 Billion By 2027. Growth, Trends, COVID-19 Impact, And Forecasts By Arizton

(MENAFN- GlobeNewsWire - Nasdaq)

Chicago, Sept. 20, 2022 (GLOBE NEWSWIRE) -- According to Arizton latest research report, l ive cell imaging market is expected to grow at a CAGR of 8.44% during 2022-2027. The major use of fluorescence microscopy techniques by researchers from pharma & biotech companies, academic institutions, and research centers further drives the demand for live-cell imaging. AI and machine learning in live-cell imaging will contribute to the market's growth in the upcoming years.

Live Cell Imaging Market Report Scope

Report Attributes Details
MARKET SIZE (2027) $3.54 Billion
MARKET SIZE (2021) $2.18 Billion
CAGR (2022-2028) 8.44%
MARKET SEGMENTS Product Type, Technique Type, Application Type, End-User Type
GEOGRAPHIC ANALYSIS North America, Europe, APAC, Latin America, and Middle East & Africa

Click Here to Download the Free Sample Report

Market Insights

  • The global live-cell imaging market is expected to witness incremental and absolute growth of $1.3 billion and 62.6%, respectively, during the forecast period.
  • In 2021, the equipment segment accounted for the highest share (52.10%) of the global live-cell imaging market.
  • In 2021, fluorescence microscopy accounted for the highest share (53.68%) of the global live-cell imaging market based on technique. It is likely to witness the highest CAGR of 8.83% during the forecast period.
  • In 2021, cell biology accounted for the highest share (38.72%) of the global live-cell imaging market based on application.
  • Most leading market players focus on product launches and approvals, marketing and promotional activities, and R&D investments to enhance their share and presence in the market.
  • Vendors also focus on market expansion in existing and new markets to cater to the needs of the large customer base, widen their product portfolios, and boost their production capabilities to attract end-users.
  • In 2021, pharma & biotech companies accounted for the highest share (47.25%) of the global live-cell imaging market based on end-user.
  • In 2021, North America accounted for the highest share (36.35%) of the global live-cell imaging market.
  • Global players with well-established infrastructure and R&D support expand their footprints in the market. Thus, small, and emerging vendors may find it increasingly difficult to compete with them in terms of innovation, brand image, technology, and pricing.
  • Emerging players in the market must provide AI-enabled microscopes with better accuracy and capacity at competitive prices to sustain themselves in the market.

Deep Learning & Artificial Intelligence Enhance Live-cell Imaging Techniques

In live-cell imaging, the challenge of AI-based approaches is not just to detect cells but also to retrieve information from each cell without any human input. AI can significantly streamline the data analysis process by overcoming these challenges. Imaging in low light conditions and imaging without fluorescent labels are two examples of life science microscopy applications where AI-based image analysis holds great promise.

AI or machine learning enables the identification of Alzheimer's patients by interpreting a combination of retinal images.

  • Scientists developed a deep learning model that can determine biomarker imaging on screening mammograms to predict the risk of breast cancer in patients.
  • AI provides feedback to physicians interacting with patients by indicating overlooked cues or concerns to improve diagnoses and management.
  • Targeted nanorobots are a novel drug delivery system.
  • Neural network algorithms can accurately grade gliomas and cervical and breast cancers and identify various stages of cancers.
  • Artificial neural networks, such as AlexNet and GoogLeNet, can accurately distinguish between normal and tuberculosis chest X-ray images after pretraining.

Recent Developments in Global Live-cell imaging Market

  • In 2021, CytoSMART Technologies launched the CytoSMART Lux3 BR, a new type of brightfield microscope. It is a live-cell imaging microscope with a high-quality complementary metal oxide semiconductor (CMOS) camera to assist label-free cell imaging procedures.
  • In 2021, the Zeiss Group announced the launch of its Zeiss Visioner 1, a Zeiss live-cell imaging system and innovative digital microscope that facilitates real-time, all-in-one focus through a micro-mirror array system.
  • In 2020, CytoSMART Technologies launched the CytoSMART Multi Lux, a remote live-cell imaging system.
  • In 2020, Etaluma partnered with innoME GmbH to introduce entry-level incubator cell imaging to the Americas.

Key Vendors

  • Danaher
  • Agilent Technologies
  • PerkinElmer
  • Merck KGaA
  • Thermo Fisher Scientific

Other Prominent Vendors

  • Axion BioSystems
  • BD
  • Bio-Rad Laboratories
  • Blue-Ray Biotech
  • Bruker
  • Eppendorf
  • Etaluma
  • Grace Bio-Labs
  • ibidi GmbH
  • Intelligent Imaging Innovations
  • Logos Biosystems
  • NanoEntek
  • Nanolive SA
  • Nikon
  • Evident
  • ONI
  • Oxford Instruments
  • Phase Focus
  • Phase Holographic Imaging PHI AB
  • Proteintech Group
  • Sartorius AG
  • Sony Biotechnology
  • Tomocube

Market Segmentation

Product Type

  • Equipment
  • Consumables
  • Software


  • Fluorescence microscopy
  • Confocal microscopy
  • Transmitted light microscopy
  • Others


  • Cell Biology
  • Drug Discovery
  • Developmental Biology
  • Stem Cells


  • Pharma & Biotech Companies
  • Academic & research centers
  • Others


  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • APAC
    • Japan
    • China
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • South Africa
    • UAE

Explore our healthcare lifesciences profile to know more about the industry.

Click Here to Download the Free Sample Report

Read some of the top-selling reports:

  • 3D Medical Imaging Market - Global Outlook & Forecast 2022-2027
  • AI In Medical Imaging Market - Global Outlook & Forecast 2022-2027
  • Mobile Medical Imaging Services Market - Global Outlook & Forecast 2022-2027
  • Medical Imaging Software Market - Global Outlook and Forecast 2021-2026

About Arizton :

Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals, and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.

Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Click Here to Contact Us

Call: +1-312-235-2040
+1 302 469 0707


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.